Zdrowie i gospodarka · 14/04/2010
FDA Removes Essential-Use Designations for Certain Inhalers Containing Ozone-Depleting Substances
The FDA is amending its regulation to remove essential-use designations for certain inhalers containing ozone-depleting substances, allowing for the reformulation of these products without releasing ODSs, effective as of a specified date.